[Effect of daunomycin and adriamycin in cytostatic combination therapy of acute leukoses of the adult].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002228:Carbenicillin / Q000009:adverse effects; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D004357:Drug Synergism; D005260:Female; D006027:Glycosides; D006197:Hair; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D012871:Skin Diseases / Q000139:chemically induced; D014750:Vincristine / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D006027:Glycosides; D003561:Cytarabine; D014750:Vincristine; D011239:Prednisolone; D002228:Carbenicillin; D003630:Daunorubicin
Zur Wirkung von Daunomycin und Adriamycin im Rahmen der zytostatischen Kombinationstherapei akuter Leukosen Erwachsener.